ArticleFrontiers in veterinary science2025
Evaluation of the pathogenicity of a rescued avian metapneumovirus subtype B strain in China.
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Avian metapneumovirus sub-type B (aMPV-B) is now widespread in China, causing significant declines in egg production among layer hens. However, the characteristics of sub-clinical infections and co-infections often resulted in low viral isolation rates, impeding research on its pathogenic mechanisms. To clarify the pathogenicity of Chinese aMPV-B field strains, we generated a strain B1 using reverse genetics and evaluated its pathogenicity in specific-pathogen-free (SPF) chickens. The complete 13,516 nt genome of strain B1 was assembled through segmented sequencing and alignment, exhibiting 96.5 to 98.7% sequence homology with prototype sub-type B strains, and > 98.6% identity with Chinese isolates. The rescued strain B1 was generated using a three-plasmid rescue system. In Vero cells, the rescued B1 induced characteristic syncytium formation, reaching the peak of the viral titer at 5 days post-infection (dpi). SPF chickens inoculated intranasally exhibited mild clinical signs dominated by nasal scratching and head shaking. The symptoms persisted for approximately 10 days, with the most severe at 5 days post-challenge (dpc). Oropharyngeal viral shedding peaked at 3 dpc and lasted around 7 days, and the predominant viral replication was in the upper respiratory tract, causing mucosal damage to nasal turbinates. Moreover, a challenge dose >10
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.